Position in QGEN
as of Jun 30, 2026
· filed Aug 20, 2026
Position Value
$366,640
-$30,116 QoQ
Shares Held
9,377
-5.4% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#205
of 336 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in QGEN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Rehmann Capital Advisory Group holds $4,513,566 across 8 Diagnostics & Research names. QGEN ranks #6 (8.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LH |
Labcorp Holdings Inc.
|
3,655 | $1,023,400 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
1,958 | $981,662 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
3,084 | $595,890 | |
| 4 | DHR |
Danaher Corp /De/
|
3,084 | $587,440 | |
| 5 | A |
Agilent Technologies, Inc.
|
2,856 | $379,362 | |
| 6 | QGEN |
Qiagen N.V.
This page
|
9,377 | $366,640 | |
| 7 | WAT |
Waters Corp /De/
|
846 | $317,283 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
205 | $261,889 |
All Filings in QGEN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $366,640 | 9,377 | Shares | Sole | 2026-08-20 | |
| 2026-03-31 | $396,756 | 9,909 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $376,443 | 8,371 | Shares | Sole | 2026-03-04 | |
| 2025-09-30 | $398,545 | 8,920 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $380,346 | 7,914 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $218,175 | 5,434 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $321,373 | 7,217 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $242,386 | 5,319 | Shares | Sole | 2024-11-18 | |
| 2024-06-30 | $212,764 | 5,178 | Shares | Sole | 2024-08-12 | |
| No filing history on record for this holder in this stock. | ||||||